Skip to content
Disclosery

EXANE DERIVATIVES: NEM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NEM, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,857 NEM shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,857 shares
    Change vs previous 13F -6,324 shares

    0.06% of the 13F portfolio, value $110,783.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 8,181 shares
    Change vs previous 13F +7,394 shares

    0.18% of the 13F portfolio, value $649,932.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 787 shares
    Change vs previous 13F -7,867 shares

    0.01% of the 13F portfolio, value $48,807.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 8,654 shares
    Change vs previous 13F +982 shares

    0.12% of the 13F portfolio, value $469,889.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 7,672 shares
    Change vs previous 13F -4,935 shares

    0.11% of the 13F portfolio, value $486,160.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 12,607 shares
    Change vs previous 13F +3,671 shares

    0.23% of the 13F portfolio, value $759,778.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 8,936 shares
    Change vs previous 13F -722 shares

    0.16% of the 13F portfolio, value $535,143.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 9,658 shares
    Change vs previous 13F not available

    0.2% of the 13F portfolio, value $612,775.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).